Toronto, Canada

Kenji Murata

This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignee: University Health Network. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Murata. Retrieved from https://idiyas.com/inventor/kenji-murata-5dbt2ttr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kenji Murata: Innovator in T Cell Receptor Technology

Introduction

Kenji Murata is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of immunology, particularly in the development of T cell receptors. With a total of 6 patents to his name, Murata's work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Among his latest innovations, Murata has focused on T cell receptors and methods of use thereof. These patents represent cutting-edge advancements in the understanding and application of T cell technology in medical treatments.

Career Highlights

Kenji Murata is affiliated with the University Health Network, where he continues to push the boundaries of research in immunology. His work is characterized by a commitment to improving health outcomes through innovative scientific solutions.

Collaborations

Murata has collaborated with notable colleagues, including Naoto Hirano and Munehide Nakatsugawa. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

Kenji Murata's contributions to the field of T cell receptor technology exemplify the spirit of innovation in modern science. His work not only advances our understanding of immunology but also holds promise for future medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…